ZBH EBITDA
Period ending:
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
ZBH ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 28 observations from Dec 31, 1998 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| 2,217,400,000 | |
| 2,250,900,000 | |
| 2,220,200,000 | |
| 1,494,700,000 | |
| 1,645,100,000 | |
| 1,005,300,000 | |
| 2,138,800,000 | |
| 1,058,700,000 | |
| 1,852,600,000 | |
| 1,793,900,000 | |
| 1,152,200,000 | |
| 1,378,300,000 | |
| 1,409,700,000 | |
| 1,426,100,000 | |
| 1,394,100,000 | |
| 1,260,600,000 | |
| 1,472,400,000 | |
| 1,433,600,000 | |
| 1,382,800,000 | |
| 1,368,700,000 | |
| 1,297,300,000 | |
| 1,025,600,000 | |
| 644,800,000 | |
| 426,200,000 | |
| 271,700,000 | |
| 291,100,000 | |
| 253,000,000 | |
| 237,000,000 |
Compare ebitda
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) ebitda
- Johnson & Johnson (JNJ) ebitda
- AbbVie (ABBV) ebitda
- UnitedHealth Group (UNH) ebitda
- Merck & Co. (MRK) ebitda
- Thermo Fisher Scientific (TMO) ebitda
- Amgen (AMGN) ebitda
- Gilead Sciences (GILD) ebitda
All ZBH financial metrics · ZBH stock overview · How to interpret financial metrics